Advancement in the modelling and therapeutics of Parkinson’s disease
- 1 March 2020
- journal article
- review article
- Published by Elsevier in Journal of Chemical Neuroanatomy
- Vol. 104, 101752
Abstract
No abstract availableKeywords
This publication has 242 references indexed in Scilit:
- Animal models of the non-motor features of Parkinson's diseaseNeurobiology of Disease, 2012
- Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron DeathNeuron, 2011
- LRRK2 Mutant iPSC-Derived DA Neurons Demonstrate Increased Susceptibility to Oxidative StressCell Stem Cell, 2011
- Efficient Generation of Functional Dopaminergic Neurons from Human Induced Pluripotent Stem Cells Under Defined ConditionsStem Cells, 2010
- Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- PINK1-Associated Parkinson's Disease Is Caused by Neuronal Vulnerability to Calcium-Induced Cell DeathMolecular Cell, 2009
- Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming FactorsCell, 2009
- Genetics of iron regulation and the possible role of iron in Parkinson's diseaseNeurobiology of Disease, 2008
- Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's diseaseFree Radical Biology and Medicine, 2008
- Animal models of Parkinson’s disease progressionActa Neuropathologica, 2008